Samsung is primed to poach more of the wearables market: The tech giant unveiled its latest UI development for its Galaxy Watch—this, combined with its collaboration with Google could beef up its competitive edge in the wearables market.
COVID-19-focused organizations vie to remain relevant: Two COVID-19-focused healthcare orgs are merging as the Delta variant approaches the US—we unpack how their combined operations could hold water once the pandemic fizzles out of the picture.
Telehealth usage continues to fall, but it’s not doomed: While new data highlights the decline in telehealth usage, adoption is still far higher than pre-pandemic—we unpack how telehealth vendors can hold consumer appetite for the long haul.
The bill that could help fuel telehealth expansion: Lawmakers proposed Cures 2.0 Act, the successor bill of the 21st Century Cures Act—here’s how it could help cushion provider and telehealth vendors’ pockets beyond the pandemic.
Collaboration is key to solving interoperability woes: Health tech startup Seqster is teaming up with CommonWell Health Alliance to fast-track interoperability efforts across the US—here’s why widespread interoperability calls for cross-industry collaboration.
MDLive unveiled new data showing it captured patients who were otherwise forgoing primary care. We unpack why virtual primary care alone is not enough to sustain consumers in the post-pandemic future.
Health passports could leave travelers homesick
Payers iron out wrinkles in social determinants of health programs: Priority Health launched a project alongside three leading SDOH startups that could solve a major pain point in social health projects: quantifying health factors like food insecurity.
Hims&Hers puts more skin in the D2C healthcare game: The telehealth company is acquiring teledermatology startup Apostrophe—here’s how its telehealth expansion strategy across specialties will help it meet consumer demand.
Pear Therapeutics announced it’s going public via a $1.6B SPAC merger—while we think it could trigger a string of digital therapeutics M&As, CMS reimbursement will be the key to wide-scale expansion.